Neurocrine Biosciences: Q2 Earnings Insights

Neurocrine Biosciences NBIX reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences beat estimated earnings by 42.37%, reporting an EPS of $0.84 versus an estimate of $0.59.

Revenue was up $89.30 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 3.53% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.